Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.44 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.44 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 5/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3872197 | 0.79 | EHMT2 (0.44) | EHMT2EHMT1APOBEC3GALDH1A1LMNA | |
| SCHEMBL2608495 | 0.79 | LMNA (0.47) | EHMT2EHMT1APOBEC3GALDH1A1LMNA | |
| SCHEMBL5633792 | 0.75 | EHMT2 (0.56) | EHMT2EHMT1APOBEC3GALDH1A1LMNA | |
| SCHEMBL450118 | 0.75 | CES2 (0.46) | ALDH1A1LMNAKMT2APKMPOLB | |
| SCHEMBL11865903 | 0.75 | CES2 (0.46) | ALDH1A1LMNAKMT2APKMPOLB | |
| SCHEMBL3075428 | 0.75 | EHMT2 (0.56) | EHMT2EHMT1APOBEC3GALDH1A1LMNA | |
| SCHEMBL4351146 | 0.75 | LMNA (0.44) | EHMT2EHMT1APOBEC3GALDH1A1LMNA | |
| SCHEMBL1479297 | 0.74 | ALDH1A1 (0.55) | EHMT2EHMT1APOBEC3GALDH1A1LMNA | |
| SCHEMBL101751 | 0.74 | LMNA (0.48) | ALDH1A1LMNAKMT2AMEN1PKM | |
| SCHEMBL28960343 | 0.74 | CES2 (0.45) | ALDH1A1LMNAKMT2APKMPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117832456-A | Preparation method of rare earth doped amorphous carbon coated silicon-carbon composite material | 云南坤天新能源有限公司 | 2024-04-05 | — | — | CN | claimed |
| US-12570647-B2 | Amino benzothiazole compounds for treatment of antibiotic resistant bacteria | SAINT LOUIS UNIVERSITY (US) | 2026-03-10 | — | — | US | disclosed |
| CN-114829543-B | Aromatic isothiocyanates | 默克专利股份有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-117832456-A | Preparation method of rare earth doped amorphous carbon coated silicon-carbon composite material | 云南坤天新能源有限公司 | 2024-04-05 | — | — | CN | disclosed |
| US-20220267312-A1 | AMINO BENZOTHIAZOLE COMPOUNDS FOR TREATMENT OF ANTIBIOTIC RESISTANT BACTERIA | SAINT LOUIS UNIVERSITY (US) | 2022-08-25 | — | — | US | disclosed |
| CN-114829543-A | Aromatic isothiocyanates | 默克专利股份有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114302872-A | Aromatic isothiocyanates | 默克专利股份有限公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-113056288-A | Macrocyclic complexes of radionuclides and their use in radiotherapy of cancer | 康奈尔大学 | 2021-06-29 | — | — | CN | disclosed |
| US-8062756-B2 | Stepwise growth of oligomeric redox-active molecules on a surface without the use of protecting groups | The Regents oft the University of California (US) | 2011-11-22 | — | — | US | disclosed |
| WO-2011122815-A2 | NOVEL QUINOXALINE DERIVATIVES | DONG-A PHARM.CO.,LTD. (KR) | 2011-10-06 | — | — | WO | disclosed |
| US-6011032-A | Heterocyclic compounds for treating myocardial ischemia | PIERRE FABRE MEDICAMENT (FR) | 2000-01-04 | — | — | US | disclosed |
| EP-0934940-A1 | CYTOKINE PRODUCTION INHIBITORS, TRIAZEPINE COMPOUNDS, AND INTERMEDIATES THEREOF | Japan Tobacco Inc. (JP) | 1999-08-11 | — | — | EP | disclosed |
| US-5767256-A | REACTING HYDROXYL GROUP-CONTAINING ACCEPTOR WITH DONOR SELECTED FROM O-PYRANOSYL AND O-FURANOSYL GLYCOSIDES HAVING PYRIDINE-CONTAINING LEAVING GROUPS | HANESSIAN STEPHEN (CA) | 1998-06-16 | — | — | US | disclosed |
| EP-0842174-A1 | HETEROCYCLIC COMPOUNDS FOR TREATING MYOCARDIAL ISCHAEMIA | PIERRE FABRE MEDICAMENT (FR) | 1998-05-20 | — | — | EP | disclosed |
| WO-1997005134-A1 | HETEROCYCLIC COMPOUNDS FOR TREATING MYOCARDIAL ISCHAEMIA | PIERRE FABRE MEDICAMENT (FR) | 1997-02-13 | — | — | WO | disclosed |
| WO-1995003316-A3 | SOLUTION AND SOLID PHASE STEREOCONTROLLED GLYCOSIDATION | HANESSIAN STEPHEN (CA) | 1995-03-30 | — | — | WO | disclosed |
| WO-1995003316-A2 | SOLUTION AND SOLID PHASE STEREOCONTROLLED GLYCOSIDATION | HANESSIAN STEPHEN (CA) | 1995-02-02 | — | — | WO | disclosed |
| WO-1995003316-A2 | SOLUTION AND SOLID PHASE STEREOCONTROLLED GLYCOSIDATION | HANESSIAN STEPHEN (CA) | 1995-02-02 | — | — | WO | disclosed |
| WO-1994026715-A1 | AMIDINE DERIVATIVES AS GASTRIC ACID SECRETION INHIBITORS | SMITHKLINE BEECHAM PLC (GB) | 1994-11-24 | — | — | WO | disclosed |
| WO-1990015058-A1 | HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY | THE UPJOHN COMPANY (US) | 1990-12-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220267312-A1 | AMINO BENZOTHIAZOLE COMPOUNDS FOR TREATMENT OF ANTIBIOTIC RESISTANT BACTERIA | BCAT2, BCAT1, ABAT | EHMT2 3290/4885EHMT1 3251/4885APOBEC3G 4429/4885 |
| US-12570647-B2 | Amino benzothiazole compounds for treatment of antibiotic resistant bacteria | BCAT1, BCAT2, IL4I1 | EHMT2 3055/4885EHMT1 1839/4885APOBEC3G 4578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.